IFNA1 and Sepsis: To partly account for these confounders, we validated our results in several ways including cross-validation and leaving 20% of the acquired studies unprocessed for independent testing, acquisition of independent validation datasets and testing the gene signatures of IFN+ and IFN- TB on a different disease - sepsis.